Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 126

1.

Successful multiple organ donation after donor brain death due to Actinomyces israelii meningitis.

Lagunes L, Len O, Sandiumenge A, Martínez-Saez E, Pumarola T, Bodro M, Macías A, Silva JT, Nuvials FX, Charco R, Moreso F, Pont T.

Transpl Infect Dis. 2017 Apr 21. doi: 10.1111/tid.12711. [Epub ahead of print]

PMID:
28429866
2.

Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.

Lai Q, Feys E, Karam V, Adam R, Klempnauer J, Oliverius M, Mazzaferro V, Pascher A, Remiszewski P, Isoniemi H, Pirenne J, Foss A, Ericzon BG, Markovic S, Lerut JP; European Liver Intestine Transplant Association (ELITA)..

Transplantation. 2017 Mar;101(3):555-564. doi: 10.1097/TP.0000000000001603.

PMID:
28212256
3.

Isolated bilateral Tapia's syndrome after liver transplantation: A case report and review of the literature.

Bilbao I, Dopazo C, Caralt M, Castells L, Pando E, Gantxegi A, Charco R.

World J Hepatol. 2016 Dec 28;8(36):1637-1644. doi: 10.4254/wjh.v8.i36.1637.

4.

 Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant.

Castells L, Llaneras J, Campos-Varela I, Bilbao I, Crespo M, Len O, Rodríguez-Frías F, Charco R, Salcedo T, Esteban JI, Esteban-Mur R.

Ann Hepatol. 2017 Jan-Feb 2017;16(1):86-93. doi: 10.5604/16652681.1226819.

PMID:
28051797
5.

Does Matching Donor-Recipient Age Affect Long-Term Survival in Liver Transplantation?

Dopazo C, Bilbao I, Castells L, Caralt M, Fernández de Sevilla E, Lázaro JL, Charco R.

Ann Transplant. 2016 Nov 18;21:708-716.

6.

Safety and Efficacy of Early Everolimus When Calcineurin Inhibitors Are Not Recommended in Orthotopic Liver Transplantation.

Gastaca M, Bilbao I, Jimenez M, Bustamante J, Dopazo C, Gonzalez R, Charco R, Santoyo J, Ortiz de Urbina J.

Transplant Proc. 2016 Sep;48(7):2506-2509. doi: 10.1016/j.transproceed.2016.08.027.

PMID:
27742336
7.

Acute Antibody-Mediated Rejection as Cause of Late Liver Allograft Failure: A Case Report.

Vellalta G, Dopazo C, Bilbao I, Castells L, Sapisochin G, Lázaro JL, Montero Á, Salcedo MT, Caralt M, Charco R.

Transplant Proc. 2015 Dec;47(10):3016-9. doi: 10.1016/j.transproceed.2015.10.036.

PMID:
26707330
8.

Initial experience in sentinel lymph node detection in pancreatic cancer.

Beisani M, Roca I, Cardenas R, Blanco L, Abu-Suboh M, Dot J, Armengol JR, Olsina JJ, Balsells J, Charco R, Castell J.

Rev Esp Med Nucl Imagen Mol. 2016 Sep-Oct;35(5):287-91. doi: 10.1016/j.remn.2015.10.006. Epub 2015 Dec 3. English, Spanish.

PMID:
26670326
9.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.

Agüero F, Forner A, Manzardo C, Valdivieso A, Blanes M, Barcena R, Rafecas A, Castells L, Abradelo M, Torre-Cisneros J, Gonzalez-Dieguez L, Salcedo M, Serrano T, Jimenez-Perez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators..

Hepatology. 2016 Feb;63(2):488-98. doi: 10.1002/hep.28321. Epub 2016 Jan 4.

PMID:
26516761
10.

Liver transplantation for cholangiocarcinoma: Current status and new insights.

Sapisochín G, Fernández de Sevilla E, Echeverri J, Charco R.

World J Hepatol. 2015 Oct 8;7(22):2396-403. doi: 10.4254/wjh.v7.i22.2396. Review.

11.

Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study.

Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miró JM; FIPSE/NIH HIVTR/NEAT023 Investigators..

Am J Transplant. 2016 Feb;16(2):679-87. doi: 10.1111/ajt.13461. Epub 2015 Sep 28.

12.

[V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].

Pardo F, Pons JA, Briceño J; en nombre de la Sociedad Española de Trasplante Hepático..

Gastroenterol Hepatol. 2015 Dec;38(10):600-18. doi: 10.1016/j.gastrohep.2015.06.008. Epub 2015 Sep 26. Spanish.

PMID:
26404045
13.

Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.

Arqués O, Chicote I, Puig I, Tenbaum SP, Argilés G, Dienstmann R, Fernández N, Caratù G, Matito J, Silberschmidt D, Rodon J, Landolfi S, Prat A, Espín E, Charco R, Nuciforo P, Vivancos A, Shao W, Tabernero J, Palmer HG.

Clin Cancer Res. 2016 Feb 1;22(3):644-56. doi: 10.1158/1078-0432.CCR-14-3081. Epub 2015 Jul 29.

14.

Long-term results of pancreaticoduodenectomy with superior mesenteric and portal vein resection for ductal adenocarcinoma in the head of the pancreas.

Landi F, Dopazo C, Sapisochin G, Beisani M, Blanco L, Caralt M, Balsells J, Charco R.

Cir Esp. 2015 Oct;93(8):522-9. doi: 10.1016/j.ciresp.2015.04.001. Epub 2015 May 14. English, Spanish.

15.

Analysis of adult 20-year survivors after liver transplantation.

Dopazo C, Bilbao I, Castells LL, Sapisochin G, Moreiras C, Campos-Varela I, Echeverri J, Caralt M, Lázaro JL, Charco R.

Hepatol Int. 2015 Jul;9(3):461-70. doi: 10.1007/s12072-014-9577-x. Epub 2014 Sep 18.

16.

Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.

Sapisochin G, Goldaracena N, Astete S, Laurence JM, Davidson D, Rafael E, Castells L, Sandroussi C, Bilbao I, Dopazo C, Grant DR, Lázaro JL, Caralt M, Ghanekar A, McGilvray ID, Lilly L, Cattral MS, Selzner M, Charco R, Greig PD.

Ann Surg Oncol. 2015 Jul;22(7):2286-94. doi: 10.1245/s10434-014-4273-6. Epub 2014 Dec 4.

PMID:
25472651
17.

Management of "very early" hepatocellular carcinoma on cirrhotic patients.

Sapisochin G, de Sevilla EF, Echeverri J, Charco R.

World J Hepatol. 2014 Nov 27;6(11):766-75. doi: 10.4254/wjh.v6.i11.766. Review.

18.

Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity.

Bilbao I, Dopazo C, Castells L, Lazaro J, Caralt M, Sapisochin G, Charco R.

Transplant Proc. 2014 Nov;46(9):3104-7. doi: 10.1016/j.transproceed.2014.10.001.

PMID:
25420835
19.

Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.

Castells L, Rimola A, Manzardo C, Valdivieso A, Montero JL, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, González-García J, Esteban-Mur JI, Miro JM; FIPSE LT-HIV Investigators..

J Hepatol. 2015 Jan;62(1):92-100. doi: 10.1016/j.jhep.2014.07.034. Epub 2014 Aug 13. Erratum in: J Hepatol. 2016 Mar;64(3):757.

PMID:
25127748
20.

Multiple indications for everolimus after liver transplantation in current clinical practice.

Bilbao I, Dopazo C, Lazaro J, Castells L, Caralt M, Sapisochin G, Charco R.

World J Transplant. 2014 Jun 24;4(2):122-32. doi: 10.5500/wjt.v4.i2.122.

Supplemental Content

Loading ...
Support Center